The PRECIS-2 tool: designing trials that are fit for purpose
2015 · BMJ · 1,693 citations
https://doi.org/10.1136/bmj.h2147
P
Peter T. Donnan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
426
Papers
19.5K
Citations
75
h-index
216
i10-index
Peter T. Donnan is an academic researcher from University of Dundee. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Liver Disease Diagnosis and Treatment & Blood Pressure and Hypertension Studies. The author has an h-index of 75, co-authored 363 publications.
ORCID: 0000-0001-7828-0610Papers by this author
worksEarly Treatment with Prednisolone or Acyclovir in Bell's Palsy
2007 · New England Journal of Medicine · 742 citations
https://doi.org/10.1056/nejmoa072006
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
2013 · British Journal of Cancer · 293 citations
https://doi.org/10.1038/bjc.2013.116
Epidemiology and outcomes of people with dementia, delirium, and unspecified cognitive impairment in the general hospital: prospective cohort study of 10,014 admissions
2017 · BMC Medicine · 237 citations
https://doi.org/10.1186/s12916-017-0899-0
Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial
2020 · Diabetes Care · 200 citations
https://doi.org/10.2337/dc19-2187
Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas
2004 · British Journal of Cancer · 108 citations
https://doi.org/10.1038/sj.bjc.6601753
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat